Norges Bank’s Alto Neuroscience ANRO Stock Holding History

Norges Bank’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-76,672	Closed	-$820K	–	1973
2024 Q2	$820K	Buy	76,672 +47,799	+166%	+$622K	﹤0.01%	1833
2024 Q1	$443K	Buy	+28,873	New	+$452K	﹤0.01%	1846

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Norges Bank's ANRO Position: Q3 2024 in Review

Norges Bank sold out of Alto Neuroscience (ANRO) in Q3 2024, closing a stake of 76,672 shares — an estimated $820K sold.

Norges Bank first reported a position in ANRO in Q1 2024 and held it in 2 quarters. The position peaked at $820K in Q2 2024. 75 funds tracked by Wall St. Rank hold ANRO as of Q3 2024.

Norges Bank reported no remaining Alto Neuroscience position as of Q3 2024 after selling out during the quarter.
Norges Bank sold 76,672 Alto Neuroscience shares in Q3 2024, an estimated $820K.
Norges Bank first reported a position in Alto Neuroscience in Q1 2024 and held it in 2 quarters.
Norges Bank's Alto Neuroscience position peaked at $820K in Q2 2024.
75 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2024.

Based on Norges Bank's 13F filing for Q3 2024, filed 13 Nov 2024.